Aktieanalys

Physitrack: Cost savings and streamlining of Champion Health - Redeye

{newsItem.title}

Redeye Publicerad: 14 Jan 07:22

Redeye briefly comments on Physitrack’s announcement to streamline its subsidiary, Champion Health, and the settlement of the share purchase (earnout) agreement. The rationalisation of Champion Health targets annual cost savings of GBP0.4m, with GBP0.2m expected in 2025.

Länk till analysen i sin helhet: https://www.redeye.se/research/1067683/physitrack-cost-savings-and-streamlining-of-champion-health?utm_source=finwire&utm_medium=RSS

Nyheter om Physitrack

Läses av andra just nu

Om aktien Physitrack

Senaste nytt